Research ArticleCardiovascular
Modulation of Resistance Artery Tone by the Trace Amine β-Phenylethylamine: Dual Indirect Sympathomimetic and α1-Adrenoceptor Blocking Actions
Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
Deepak Narang
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Paul M. Kerr
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Stephanie E. Lunn
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Rhys Beaudry
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Julie Sigurdson
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Margaret D. Lalies
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Alan L. Hudson
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Peter E. Light
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Andrew Holt
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Frances Plane
Department of Pharmacology (D.N., P.M.K., S.E.L., R.B., J.S., M.D.L., A.L.H., P.E.L., A.H., F.P.), and Cardiovascular Research Centre (P.E.L., F.P.), University of Alberta, Edmonton, Alberta, Canada
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
β-Phenylethylamine and Vascular Tone
Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
Journal of Pharmacology and Experimental Therapeutics October 1, 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
Research ArticleCardiovascular
β-Phenylethylamine and Vascular Tone
Deepak Narang, Paul M. Kerr, Stephanie E. Lunn, Rhys Beaudry, Julie Sigurdson, Margaret D. Lalies, Alan L. Hudson, Peter E. Light, Andrew Holt and Frances Plane
Journal of Pharmacology and Experimental Therapeutics October 1, 2014, 351 (1) 164-171; DOI: https://doi.org/10.1124/jpet.114.216523
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement